Invention Grant
- Patent Title: Botulinum toxin treatments of neurological and neuropsychiatric disorders
-
Application No.: US15447770Application Date: 2017-03-02
-
Publication No.: US10064921B2Publication Date: 2018-09-04
- Inventor: Andrew M. Blumenfeld
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Brigitte C. Phan; Ted A. Chan
- Main IPC: A61K38/48
- IPC: A61K38/48 ; A61K9/00
Abstract:
Methods for preventing or treating neuropsychiatric disorder and/or a neurological disorder including a neurological disorder mediated by the thalamus. Neuropsychiatric disorders and/or a neurological disorders, including a thalamically mediated disorder can be treated by peripheral administration of a botulinum toxin to or to the vicinity of a trigeminal sensory nerve, thereby preventing or treating a neurological disorder and/or a neuropsychiatric disorder.
Public/Granted literature
- US20170173123A1 BOTULINUM TOXIN TREATMENTS OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS Public/Granted day:2017-06-22
Information query
IPC分类:
